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Pattern recognition receptors (PRRs) expressed in antigen-presenting cells are thought 13 
to shape pathogen-specific immunity by inducing secretion of co-stimulatory 14 
cytokines during T-cell activation, yet data to support this notion in vivo is 15 
surprisingly scarce. Here we show that the cytosolic PRR Nod-like Receptor CARD 4 16 
(NLRC4) suppresses, rather than facilitates, effector and memory CD4+ T-cell 17 
responses against Salmonella in mice. NLRC4 negatively regulates immunological 18 
memory by preventing delayed activation of the cytosolic PRR NLR pyrin domain 3 19 
(NLRP3) that would otherwise amplify the production of cytokines important for the 20 
generation of Th1 immunity such as intereukin-18. Consistent with a role for NLRC4 21 
in memory immunity, primary challenge with Salmonella expressing flagellin 22 
modified to largely evade NLRC4 recognition significantly increases protection 23 
against lethal re-challenge. This finding suggests flagellin modification to reduce 24 
NLRC4 activation enhances protective immunity which could have important 25 
implications for vaccine development against flagellated microbial pathogens. 26 
  27 
 3
Antigen presenting cells (APCs) recognize pathogens via pattern recognition 28 
receptors (PRRs), such as the transmembrane Toll-like receptors (TLRs) and the 29 
cytosolic Nucleotide oligomerisation domain (NOD)-like receptors (NLRs)1,2. PRR 30 
activation induces APCs to secrete pro-inflammatory cytokines during presentation of 31 
antigens to naïve T cells leading to their differentiation into the most appropriate 32 
subset of activated T cells to eliminate the pathogen3. The bridge between the innate 33 
and adaptive immune systems is, therefore, formed by PRR activation in APCs. 34 
Central to this is the concept that the repertoire of PRRs expressed by APCs is crucial 35 
to the specificity of adaptive immune response generated4. The increasing prevalence 36 
of antimicrobial resistance means the development of alternative ways to combat 37 
infectious diseases is a matter of urgency. Understanding the interactions between 38 
pathogens, PRRs and pathogen-specific immunity is, therefore, important to facilitate 39 
the development of new vaccines with improved efficacy.   40 
 41 
Microbial pathogens produce a number of pathogen-associated molecular patterns 42 
(PAMPs) that are recognized by different PRRs. Lipopolysaccharide (LPS) from 43 
Gram-negative bacteria, for example, is recognized by TLR4 and flagellin by TLR5. 44 
Both flagellin and detoxified LPS molecules are used as vaccine adjuvants with 45 
flagellin being an antigenic target of antibody and CD4+ T cell responses5. The 46 
nucleotide binding oligomerisation domain (NOD)-like receptor CARD 4 (NLRC4) 47 
also recognizes microbial flagellin6,7, but, in addition, senses the type III secretion 48 
system-associated needle and rod proteins8 via the NLR family, apoptosis inhibitory 49 
protein (NAIP) 5 or NAIP6 and NAIP1 or NAIP2 in mice, respectively9-11. NLR pyrin 50 
domain 3 (NLRP3) is activated by a diverse range of triggers, including PAMPs and 51 
danger-associated molecular patterns (DAMPs). NLR activation drives the formation 52 
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of an inflammasome signalling complex12 which activates caspase-1 to process pro-53 
IL-1β and pro-IL-18 to their mature forms and cleaves gasdermin D to drive an 54 
inflammatory form of cell death called pyroptosis13,14. NLRC4 and NLRP3 can be 55 
recruited to the same inflammasome to optimise IL-1β and IL-18 release15,16.  56 
 57 
IL-1β and IL-18 have well documented effects on T cell survival, activation and 58 
differentiation17. Little is known, however, about whether and how specific 59 
inflammasome components influence the development of adaptive immunity against 60 
pathogenic bacteria and, specifically, that of immunological memory which is critical 61 
for vaccine development4. It has been shown, for example, that NLRC4 and NLRP3 62 
activation in innate immune cells optimises IFN-γ release by CD8+ and CD4+ T cells 63 
in mice challenged with Salmonella enterica serovar Typhimurium (S. Typhimurium), 64 
but this was not an antigen-specific effect18,19. Here, using the murine model of 65 
sublethal salmonellosis, we show that NLRC4 suppresses Th1 CD4+ T cell effector 66 
and memory responses against S. Typhimurium without affecting antibody 67 
production. Primary challenge with S. Typhimurium engineered to reduce NLRC4 68 
inflammasome activation resulted in increased levels of serum IL-18 and IFN-γ, 69 
enhanced Th1 CD4+ T cell memory responses and improved protection against oral 70 
re-challenge with fully-virulent Salmonella. Our data suggest that attenuation of 71 
NLRC4 activation by flagellin could improve the efficacy of live vaccines against 72 








NLRC4 restricts bacterial load in vivo and Th1 memory responses ex vivo 80 
 81 
To investigate whether NLRC4 affects the development of pathogen-specific 82 
immunity, we first challenged C57BL/6J wild-type and congenic Nlrc4-/- mice with S. 83 
Typhimurium M525P. In this model of sublethal salmonellosis, effector Th1 CD4+ T 84 
cells drive microbial clearance and establish long-term protection against re-85 
challenge20,21. Nlrc4-/- mice harboured higher microbial numbers in the liver and 86 
spleen irrespective of the route of bacterial administration (intravenous in Fig. 1a or 87 
oral in Extended Data 1a). Bacterial burden, as expected 22,23, was not significantly 88 
different  between Nlrc4-/- and wild-type mice lethally challenged with fully virulent 89 
S. Typhimurium SL1344 (Extended Data 1b). The slower kinetics of the sublethal 90 
infection reveal a clear role for NLRC4 in regulating bacterial load in vivo.  91 
 92 
We determined whether NLRC4 would play any role in the development of memory 93 
CD4+ T cell responses. Wild-type and Nlrc4-/- mice were challenged with PBS (naïve) 94 
or 104 CFU of S. Typhimurium M525P, an inoculum size that was equally 95 
immunogenic to a 10-fold higher dose in wild-type mice (Extended Data 2) and well 96 
tolerated by the Nlrc4-/- mice. To elicit a response from memory cells only, CD4+ T 97 
cells were isolated from mice which had cleared the primary infection after a 98 
minimum of 90 days. Upon stimulation with bacterial extract (antigen-specific), CD4+ 99 
T cells from naïve mice, irrespective of genotype, secreted negligible amounts of the 100 
Th1 cytokines IFN-γ and IL-2 (Fig. 1b), confirming the specificity of the response 101 
generated by CD4+ T cells from infected mice (Fig. 1c). Similarly, the amount of 102 
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IFN-γ secreted by CD4+ T cells when stimulated with anti-mouse CD3e (non antigen-103 
specific) increased more than 50-fold in response to infection (Fig. 1c).   104 
 105 
We compared the magnitude of the ex vivo memory responses between wild-type and 106 
Nlrc4-/- mice. T cells from Nlrc4-/- mice secreted more IFN-γ and IL-2 than cells from 107 
wild-type mice in response to both Salmonella antigen and anti-mouse CD3e (Fig. 108 
1c). This amplified response persisted up to 170 days after challenge (Fig. 1d, 109 
concanavalin A was used in early experiments as a polyclonal stimulus but later 110 
replaced by anti-mouse CD3e). The Th1-related cytokines TNF-α, IL-6 and GM-CSF 111 
in the CD4+ T cell culture supernatant from Nlrc4-/- mice were also elevated (Fig. 1e). 112 
These data suggest that NLRC4 activation by Salmonella specifically restricts CD4+ T 113 
cell-mediated memory immunity. 114 
 115 
We then quantified the number of CD4+ T-cells secreting IFN-γ in response to 116 
bacterial extract using ELISPOT and cytokine secretion assays. Both assays showed a 117 
larger population of IFN-γ-secreting cells in Nlrc4-/- mice (Fig. 1f and 1g). We also 118 
analysed the surface expression of CD62L and CD44 in IFN-γ+cells and found that 119 
over 90% in both wild-type and Nlrc4-/- mice had an effector memory T cell profile 120 
(CD44high CD62L-) with central memory cells (CD44high CD62L+) representing less 121 
than 5% of the population (Extended Data 3). These data suggest that NLRC4 restricts 122 
T cell memory immunity against Salmonella by reducing the size of antigen-specific 123 
memory pool.  124 
 125 
To test if NLRC4 could also affect protection against lethal re-challenge in vivo, wild-126 
type and Nlrc4-/- mice were systemically challenged with S. Typhimurium M525P 127 
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and, after clearing the primary infection, re-challenged orally with fully virulent 128 
Salmonella. Nlrc4-/- mice were only marginally better protected than their wild-type 129 
counterparts (Extended Data 4b, mean survival time of 9 days versus 8 days, 130 
respectively), an outcome that may have been affected by the different routes of 131 
infection between primary challenge (intravenous) and re-challenge (orally). In the 132 
same trial, however, naïve Nlrc4-/- mice lethally challenged with Salmonella had 133 
shorter survival times than naïve wild-type mice (Extended Data 4a, 6 days versus 8 134 
days, respectively). These data suggest that, in the absence of NLRC4, the 135 
compromised innate immune control of microbial dissemination presumably 136 
counteracts any benefits arising from augmented T-cell memory immunity. 137 
 138 
NLRC4 restricts Th1 effector responses during microbial clearance of a primary 139 
infection 140 
 141 
To determine if NLRC4 also affects the development of Th1 effector immunity, we 142 
isolated splenic CD4+ T cells from infected wild-type and Nlrc4-/- mice during an 143 
active primary infection and measured the amount of IFN-γ released ex vivo. 144 
Production of IFN-γ in response to bacterial extract was comparable between the two 145 
genotypes when CD4+ T cells were isolated early during infection (Fig. 2a, 1 and 7 146 
days). Notably, as the infection progressed into the phase of CD4+ T cell-mediated 147 
bacterial clearance, T cells from Nlrc4-/- mice secreted significantly more IFN-γ than 148 
cells from wild-type mice (Fig. 2a, 14 and 21 days). By the end of microbial 149 
clearance, however, there were no difference in Th1 responses between Nlrc4-/- and 150 
wild-type mice (Fig. 2a, 35 days). Salmonella-induced Th1 CD4+ T cell responses can 151 
also affect the development of B cell-dependent immunity24, so we measured the 152 
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levels of serum antibodies against S. Typhimurium LPS at 90 days after primary 153 
infection. We found no difference in the levels of IgG2c, IgG2b and IgM between 154 
wild-type and Nlrc4-/- mice (Fig. 2b). These data collectively show that NLRC4 155 
restricts both Th1 CD4+ T cell-mediated effector and memory immune responses 156 
against Salmonella, but has no effect on B cell-mediated immunity. 157 
 158 
Negative regulation of CD4+ T cell-mediated memory responses by NLRC4 is 159 
NLRP3-dependent 160 
 161 
NLRC4 is not expressed in naïve or activated CD4+ T cells25,26. We hypothesized, 162 
therefore, that any effect on CD4+ T cell memory immunity is most likely to occur in 163 
response to inflammasome signalling by APCs. NLRC4 and NLRP3 are both 164 
activated in murine macrophages infected with Salmonella22. We, therefore, assessed 165 
ex vivo the memory T cell responses in Nlrp3-/- and Nlrp3-/-Nlrc4-/- mice. Secretion of 166 
both IFN-γ and IL-2 was comparable between wild-type,  Nlrp3-/- or Nlrp3-/-Nlrc4-/- 167 
mice (Fig. 3a and 3b) and, as expected, we saw no difference in the numbers of CD4+ 168 
T cells secreting IFN-γ in response to bacterial extract (Fig. 3c and 3d). To confirm 169 
that our independent comparisons between wild-type and Nlrc4-/- (Fig. 1c), wild-type 170 
and Nlrp3-/- (Fig. 3a) and wild-type and Nlrp3-/-Nlrc4-/- mice (Fig. 3b) do not suffer 171 
from interexperimental variation, we compared IFN-γ production between the 172 
different groups of wild-type mice used in these experiments and found no significant 173 
difference (Extended Data 5, P=0.25 via one-way ANOVA). These data suggest that 174 
the amplification of memory CD4+ T cell responses seen the absence of Nlrc4-/- is 175 
driven by NLRP3 activation, while NLRP3 does not have an effect when NLRC4 is 176 
active. 177 
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NLRC4 restricts NLRP3-dependent production of IL-18 and IFN-γ  178 
 179 
In macrophages infected with Salmonella SL1344, NLRC4 is activated rapidly to 180 
induce caspase-1-mediated pyroptosis and IL-1β and IL-18 release27, whilst NLRP3 181 
activation is delayed to optimise IL-1β and IL-18 production without inducing 182 
pyroptosis15,22. Infection of wild-type and Nlrp3-/- macrophages with S. Typhimurium 183 
M525P resulted in pyroptotic cell death within 2 hours of infection, while Nlrc4-/- and 184 
Nlrc4-/-Nlrp3-/- cells lysed between 6 and 12 hours (Extended Data 6a). In the absence 185 
of NLRC4, cells produced IL-1β  via NLRP3 and because these cells do not rapidly 186 
die, they secrete large amounts of IL-1β between 6 and 24 hours (Extended Data 6b).  187 
 188 
Both IL-1β and IL-18 are involved in initiation and propagation of antigen-specific 189 
immunity against bacterial pathogens, therefore, we examined, whether NLRC4 and 190 
NLRP3 affect the production of these cytokines in vivo during infection with S. 191 
Typhimurium M525P. Serum IL-1β levels were below the detection limit, as 192 
expected22, throughout the course of infection. In Nlrc4-/- mice, levels of IL-18 were 193 
lower one day after challenge, but as the sublethal infection progressed, they 194 
markedly increased when compared to those detected in wild-type mice (Fig. 4b). 195 
This increase coincided with the onset of effector CD4+ T cell-driven microbial 196 
clearance with IL-18 remaining elevated in Nlrc4-/- mice for a total of 3 weeks (Fig. 197 
4b, day 7 to 28). This corresponds to the time that Nlrc4-/- mice have heightened 198 
effector CD4+ T cell responses (Fig. 2a) suggesting a link between the increased 199 
levels of IL-18 and increased Th1 immunity. 200 
 201 
 10
We tested if this rise in serum IL-18 seen in Nlrc4-/- mice was NLRP3-dependent. 202 
Nlrp3-/- and Nlrp3-/-Nlrc4-/- mice, like Nlrc4-/- mice, had decreased serum IL-18 levels 203 
very early during infection (Fig. 4b, Day 1), but, unlike Nlrc4-/- mice, did not have 204 
increased IL-18 response as the infection progressed further (Fig. 4b, day 7-28). 205 
Importantly, Nlrc4-/- and Nlrp3-/-Nlrc4-/- mice had similar bacterial burdens (Fig. 4a), 206 
but different IL-18 profiles (Fig. 4b), suggesting that this surge in serum IL-18 in the 207 
absence of NLRC4 depends on NLRP3 activation. IL-18 is a potent inducer of IFN-γ 208 
28 which is indispensable for protection against Salmonella20,29. IFN-γ levels in Nlrc4-209 
/- mice remained elevated for 3 weeks compared to those in the Nlrp3-/-Nlrc4-/- mice 210 
(Fig. 4c, day 7 to 28) matching that of the serum IL-18 production. During the early 211 
stages of infection, cells such as natural killer cells are the main source of serum IFN-212 
γ30 explaining why at day 7 Nlrc4-/- mice have higher levels of IFN-γ in the serum 213 
(Fig. 4c), but not when their CD4+ T cells are stimulated with bacterial extract ex vivo 214 
(Fig. 2a). Our data collectively suggest that, consistent with its role in downregulating 215 
CD4+ T cell memory responses, NLRC4 activation suppresses NLRP3-driven 216 
amplification of serum IL-18 and IFN-γ.  217 
 218 
S. Typhimurium expressing flagellin from non-pathogenic E. coli evades NLRC4 219 
recognition  220 
 221 
Flagellin activates both TLR5 and NAIP/NLRC4 with the latter also recognising 222 
Salmonella type III secretory proteins such as PrgJ. TLR5 is important for generating 223 
T cell immunity against S. Typhimurium31, but our data suggest that NLRC4 224 
downregulates CD4+ T cell-mediated memory, while, at the same time, enhancing 225 
host survival during the early stages of a lethal infection (Extended Data 4a). We 226 
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hypothesised that primary challenge with Salmonella genetically engineered to 227 
partially evade recognition by NLRC4, by mutating rather than deleting fliC, should 228 
retain TLR5 activation, enhance  memory immunity and, therefore, potentially 229 
increase resistance to lethal re-challenge.   230 
 231 
We genetically modified the wild-type M525P strain, which naturally lacks fljB, by 232 
replacing its native fliC with that from non-pathogenic E. coli K-12 substrain 233 
MG1655, to generate S. Typhimurium M525P ΔfliC::fliCMG1655 (M525P fliCMG1655). 234 
Comparison of the predicted FliC proteins from S. Typhimurium and E. coli K-12 235 
MG1655 showed high sequence homology at the N- and C-terminal regions of the 236 
protein, but with a variable central domain (Extended Data 7). Flagellin from this E. 237 
coli strain activates TLR5 as efficiently as flagellin from S. Typhi but is impaired in 238 
activating NLRC432. M525P fliCMG1655 also retains bacterial motility (Extended Data 239 
8a) which may be important to facilitate infection and spread into the tissues. When 240 
tested in vitro, this mutant induced less cell death and IL-1β production than the wild-241 
type strain in wild-type but not in Nlrc4-/- macrophages, but could still activate 242 
NAIP1/2-NLRC4 signalling presumably via its type III secretion system (Extended 243 
Data 8b and 8c). TNF-α production by wild-type macrophages infected with M525P 244 
fliCMG1655 or M525P were comparable (Extended Data 8d) suggesting no deficit in 245 
TLR activation. These data indicate that M525P fliCMG1655 shows reduced, but not 246 
obliterated, NLRC4 inflammasome recognition.  247 
 248 
Wild-type mice infected with M525P fliCMG1655 had a higher bacterial burden than 249 
those infected with M525P (Fig. 5a), comparable to that seen in Nlrc4-/- mice 250 
challenged with M525P (Fig. 1a). Bacterial loads of M525P and M525P fliCMG1655 251 
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were similar in Nlrc4-/- mice confirming that the increased spread of M525P fliCMG1655 252 
into the tissues was NLRC4-dependent (Fig. 5b). Serum levels of IL-18 and IFN-γ 253 
were significantly increased for two weeks (Figures 5c and 5d, day 7 to 21) in mice 254 
infected with M525P fliCMG1655 when compared to mice infected with M525P, again 255 
comparable to the differences seen between wild-type and Nlrc4-/- mice infected with 256 
M525P (compare Fig. 4b, 4c with Fig. 5c and 5d).  Infection of wild type mice with 257 
M525P fliCMG1655 did not, however, induce as high levels, or as sustained production, 258 
of IL-18 as seen in Nlrc4-/- mice infected with M525P (compare Fig. 4b with Fig. 5c). 259 
This is consistent with M525P fliCMG1655 retaining some residual capacity to activate 260 
NLRC4.  261 
 262 
Primary challenge with S. Typhimurium M525P fliCMG1655 enhances CD4+ T cell 263 
memory responses and improves protection against lethal re-challenge 264 
 265 
We compared the CD4+ T-cell memory responses between wild-type mice challenged 266 
with M525P or M525P fliCMG1655 and found them to be higher in the M525P 267 
fliCMG1655 group (Figure 6a), comparable to those seen in Nlrc4-/- mice (Fig. 1c). To 268 
determine whether primary challenge with S. Typhimurium M525P fliCMG1655 would 269 
confer any resistance against lethal re-challenge, wild-type mice were systemically 270 
infected with M525P or M525P fliCMG1655 and allowed to clear the infection before 271 
re-challenge with fully virulent SL1344. Mice initially infected with M525P survived 272 
for 8.5 days while the survival rate of mice infected with M525P fliCMG1655 was 273 
markedly increased with approximately 75% of them surviving up to 21 days post-274 
lethal re-challenge (Fig. 6b). Mice in the M525P fliCMG1655 group also lost less weight 275 
from day 4 to day 6 after re-challenge when compared to mice in the M525P group 276 
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(Fig. 6c). These data suggest that reduced NLRC4 activation during primary 277 
challenge promotes protection against re-challenge although the mechanism by which 278 
this occurs is unclear. 279 
 280 
Increased levels of serum IL-18 correlated with increased effector immunity (Fig. 2a 281 
and 4b), we, therefore, tested if IL-18 contributes to the amplification of CD4+ T cell 282 
immunity seen when NLRC4 activation is impaired. We compared the ex vivo 283 
memory responses between wild-type and IL-18-/-mice challenged with M525P and 284 
found no difference suggesting that, when NLRC4 is fully activated, IL-18 does not 285 
affect the potency of the response (Fig. 6d). When mice were challenged with M525P 286 
fliCMG1655, however, the IFN-γ response was reduced in IL-18-/- mice and, although 287 
this did not quite meet statistical significance (Fig 6e, P=0.0513) is, nevertheless, 288 




Pathogen-mediated activation of PRRs should determine the specificity of, and 293 
enhance the production of, antigen-specific immunity, yet here we show that 294 
activation of the PRR NLRC4 supresses memory CD4+ T cell-mediated responses 295 
against Salmonella. The CD4+ T cell-mediated immunity is critical for host control 296 
and long-term protection against intraphagosomal pathogens such as Salmonella. 297 
Equally important is the fact that mice initially challenged with a Salmonella strain 298 
that evades detection by NLRC4 were protected against an otherwise lethal re-299 
challenge. This work, therefore, has important implications for vaccine development 300 
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against pathogens that efficiently activate the NLRC4 inflammasome, such as 301 
Legionella33, Pseudomonas34 and Shigella35.  302 
 303 
We used inflammasome-deficient mice to show that activation of NLRC4 by S. 304 
Typhimurium curtails antigen-specific CD4+ T cell-mediated memory responses and 305 
confirmed this phenotype by using a Salmonella mutant defective in activating 306 
NLRC4. In the wild-type strain we replaced native flagellin with flagellin from E. coli 307 
that is impaired in activating NLRC4, but can still activate TLR5 and keep the mutant 308 
motile, both of which could potentially affect the development of immunity against 309 
Salmonella. This mutant enhanced antigen-specific immunity, most likely by its clear 310 
ability to evade NLRC4 activation, but it would be interesting to test if a flagellin-311 
deficient mutant would induce similar effects in vivo. 312 
 313 
Relatively little is known about whether NLRC4 can affect the development of 314 
antigen-specific immunity against pathogens. Studies investigating the effect of 315 
NLRC4 on CD8+ T cell immunity have shown contrasting results. Listeria 316 
monocytogenes constitutively expressing flagellin from Legionella pneumophila 317 
suppressed CD8+ T cell immunity in mice and failed to protect them against re-318 
challenge36. Flagellin recognition by NLRC4 during Salmonella infection, in contrast, 319 
induces IFN-γ release by memory CD8+ T cells19. A similar phenomenon has been 320 
described in Salmonella-induced CD4+ Th1 effector cells which require both NLRC4 321 
and NLRP3 to optimally secrete IFN-γ in response to LPS and flagellin18. Unlike our 322 
work, however, both these studies describe a role for NLRC4 in non antigen-specific 323 
immune responses and suggest that NLRC4 activation drives the induction, rather 324 
than downregulation, of T cell responses.   325 
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Our data show that NLRC4 activation negatively regulates CD4+ T cell-mediated 326 
memory immunity against Salmonella via an NLRP3-dependent mechanism. 327 
Salmonella engages first NLRC4 and subsequently NLRP3 which maximises IL-328 
1β/IL-18 production in vitro15,22 and is particularly important when NLRC4 activation 329 
is impaired. Our work shows that mice lacking NLRC4 have increased serum IL-18 330 
levels only when they have functional NLRP3, while  deficiency in both PRRs 331 
prevents IL-18 amplification in the serum. We hypothesise that during S. 332 
Typhimurium infection, NLRC4 prevents NLRP3 from amplifying cytokine 333 
production by APCs and this, in turn, restricts the potency of pathogen-specific 334 
immune responses. Defective NLRC4 activation by increasing the levels of Th1-335 
related cytokines in the serum enhances the expansion of antigen-specific CD4+ T 336 
cells and, consequently, this would give rise to a larger pool of memory cells. These 337 
cytokines could either be produced by the APCs during their interaction with naive T 338 
cells or by cells other than APCs at a later stage to act on activated effector T cells4.  339 
 340 
The NLRP3-dependent mechanism by which NLRC4 suppresses T cell memory 341 
responses is unclear but our data suggest that IL-18 could be important. IL-18 342 
enhances Th1 antigen-specific immunity by increasing IFNγ production from Th1 343 
CD4+ T cells and natural killer cells37. It is also important for the maintenance of 344 
potent Th1 responses against Listeria38 and promotes antigen-specific clonal 345 
expansion and survival of effector CD4+ T cells in response to flagellin39. In our 346 
model, elevated serum IL-18 coincides with increased CD4+ T cell effector responses 347 
and persists for two to three weeks during the microbial clearance phase when the vast 348 
majority of effector cells die and only a small fraction survive to become quiescent, 349 
long-lived memory cells40. We saw that when NLRC4 activation is defective, IL-18 350 
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deficiency partially prevents the amplification of memory responses. Other 351 
mechanisms may be important, however, such as the production of IL-1β which can 352 
enhance Th1 cell expansion41 or cytokine-independent mechanisms, such as 353 
phagosome acidification, which can affect the development of adaptive immunity 354 
against Gram-positive bacteria42. 355 
 356 
In conclusion, here we describe an unknown mechanism by which reduced activation 357 
of a PRR, NLRC4, enhances antigen-specific memory responses and promotes long-358 
term protection against re-challenge. This reveals a clear link between NLRC4 359 
activation and restriction of pathogen-specific immunity within a physiological 360 
setting. Whether this phenomenon is induced by the pathogen as a strategy to impede 361 
the development of optimal memory responses or by the host to avoid 362 
immunopathology by tightly regulating levels of proinflammatory cytokines remains 363 






Wild-type C57BL/6J mice were obtained from Charles River, UK. Nlrc4−/− and 370 
Nlrp3−/− mice on a C57BL/6J background (after at least 8 back crosses onto the 371 
C57BL/6J background) were kindly provided by Prof. Kate Fitzgerald (University of 372 
Massachusetts Medical School). The Nlrc4-/-Nlrp3-/- mice were generated in-house by 373 
crossing Nlrc4-/- with Nlrp3-/- mice. All mouse colonies were bred independently. 374 
Mice were genotyped by PCR using standard protocols. All mice were  maintained in 375 
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a specific pathogen-free facility according to the Animals Scientific Procedures 376 
outlined by the UK Home Office regulations. All work involving live animals 377 
complied with the University of Cambridge Ethics Committee regulations and was 378 
performed under the Home Office Project License numbers 80/2572 and 379 
P48B8DA35. Both male and female mice between 8 and 24 weeks of age were used 380 
in infection trials and as donors for primary bone marrow-derived macrophages 381 
(BMDMs).  382 
 383 
Bacterial Strains and Animal Infections  384 
 385 
S. Typhimurium strains SL1344 and M525P43, strains of high and intermediate 386 
virulence, respectively, were used in this study. For in vitro studies, S. Typhimurium 387 
was grown from single colonies to exponential phase, by inoculating a 17.5h 388 
overnight culture 1 in 10 into LB broth and incubating at 37°C, 200 rpm for 2h. For in 389 
vivo infections, stationary phase S. Typhimurium cultures were washed and 390 
resuspended in Dulbecco’s PBS (D-PBS, Sigma). For i.v. challenge experiments, 391 
0.2ml of the inoculum were administered systemically via the lateral tail vein. For 392 
oral challenge experiments, mice were lightly anesthetized with isoflurane and then 393 
inoculated with 0.2 mL of the inoculum via oral gavage. Control mice were 394 
inoculated with sterile PBS only. The exact dose of Salmonella administered was 395 
determined by serial dilution and plating the inoculum on LB plates before and after 396 
infection. Primary challenge in all experiments was performed by i.v. administration 397 
of approximately 104 CFU S. Typhimurium 525P wild-type or mutant per mouse 398 
unless mentioned otherwise. Exact doses for each experiment are given in the legends 399 
of the respective graphs. All experiments were performed after approval from the 400 
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University of Cambridge ethical review committee and under the UK government 401 
Home office regulations license numbers 80/2135, 80/11763, PF86EABB1 and 402 
P48B8DA35. In this work, no statistical methods were used to predetermine the 403 
sample size. The experiments were not randomized, and the investigators were not 404 
blinded to allocation during the experiments and outcome assessments. 405 
 406 
Humane endpoint curves  407 
 408 
In animal trials which involved  re-challenge with fully virulent S. Typhimurium, we 409 
constructed humane endpoint curves as an alternative to survival curves. To do this, 410 
mice were weighed once and assessed twice daily for manifestation of clinical signs 411 
associated with generalized infection. These include weight loss of over 15% of 412 
maximum body weight, marked piloerection, subdued behavioural pattern even when 413 
provoked and reduced exploration, isolation from peers, intermittent hunched posture 414 
and persistent oculo-nasal discharge. Mice would be euthanized without delay when 415 
any of these signs persisted for more than 12 hours. 416 
 417 
Bacterial Isolation and Enumeration 418 
 419 
Mice were euthanized at specific intervals following infection and their spleens and 420 
livers removed aseptically. Organs were homogenized in 10ml sterile water using a 421 
Colworth stomacher. Organ homogenates were serially diluted and plated on LB agar 422 
plates. LB plates were incubated overnight at 37 °C followed by enumeration of 423 
colony-forming units. In some experiments, spleens were first passed through a cell 424 
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strainer to produce single cell suspensions in RPMI, a fraction of which was then used 425 
for bacterial enumeration. 426 
 427 
Construction of S. Typhimurium M525PΔfliC::fliCE.coli and bacterial motility 428 
assays 429 
 430 
To engineer S. Typhimurium that expresses the FliC protein of the non-pathogenic E. 431 
coli K-12 strain MG1655, a DNA fragment was synthesized by GeneArt Gene 432 
Synthesis (Life Technologies) encoding E. coli K-12 MG1655 fliC adjacent to a 433 
chloramphenicol resistance cassette (CmR) and flanked by 60 bp arms homologous to 434 
the sequence immediately upstream and downstream of S. Typhimurium M525P fliC. 435 
This fliCMG1655 cassette was transformed into electrocompetent S. Typhimurium 436 
M525P cells carrying the pBADλRed plasmid44,45. Transformants were selected on 437 
LB agar supplemented with 25 ug/ml chloramphenicol  and positive clones were 438 
confirmed by sequencing. The growth rate of the mutant strain was assessed by 439 
performing viable bacterial counts and found to be similar to that of the wild-type 440 
strain (Supplementary Fig. 1). 441 
 442 
To assess bacterial motility, overnight cultures grown in LB broth were diluted into 443 
fresh LB broth to an OD600 of 0.05 and grown at 37°C until cultures reached an OD600 444 
of 1.0. Two microliters of culture were inoculated into 0.25% tryptone agar (2.5g/l 445 
agar, 10g/L tryptone, 5g/L NaCl). Plates were incubated at 37°C for between 4 and 6 446 




Cell Culture and Infections 450 
 451 
BMDMs were prepared as previously described46. They were infected with S. 452 
Typhimurium grown to exponential phase as previously described47. Cell viability 453 
was assessed using the Cytotox 96 Non-Radioactive Cytotoxicity assay (Promega).  454 
 455 
CD4+ T Cell Ex Vivo Stimulation Assays 456 
 457 
Mice were euthanized, their spleens aseptically removed and, after mechanical 458 
disruption, passed through a 70 μm cell strainer (BD Biosciences) to obtain single cell 459 
suspensions in pre-warmed RPMI containing 2% (vol/vol) FCS (Hyclone). Cell 460 
suspensions were washed once and resuspended in Red Blood Cell Lysis buffer 461 
(Sigma), mixed and incubated for 10 min on ice. Total splenocytes were washed twice 462 
and passed through a 30μ m filter (Partec). CD4+ T cells were purified using CD4 463 
microbeads and magnetic positive selection according to manufacturer’s guidelines 464 
(Miltenyi Biotec). This routinely resulted in cell populations containing over 95% 465 
CD4+ cells. CD4+ T cells were resuspended in complete RPMI medium containing 466 
10% FCS (Hyclone), 5mM L-glutamine, 100U/ml penicillin, 100μg/ml streptomycin, 467 
1mM HEPES and 0.02mM β-mercaptoethanol. Cells were seeded at 2 x 105 cells/well 468 
in round bottom 96-well plates (Greiner Bio-One) together with wild-type naïve total 469 
splenocytes previously treated (1h at 37°C and 5% CO2) with Mitomycin C 25 μg/ml 470 
(Sigma) at a 1:1 ratio (total cell number of 4 x 105 cells/well).  Co-cultures from each 471 
mouse were either left unstimulated, stimulated with 2 μg/mL anti-mouse CD3e 472 
(clone 145-2C11, ebioscience) or 20 μg/mL whole Salmonella cell extract, prepared 473 
as described previously48 and incubated at 37°C and 5% CO2. In some experiments, 474 
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the polyclonal stimulus was provided by concanavalin A (rather than anti-mouse 475 
CD3e) which was used at a final concentration of 5 μg/mL. Cell culture supernatants 476 
were collected after 24h and 72h incubation for cytokine quantification.  477 
When CD4+ T Cells were stimulated ex vivo to assess memory immunity, it was 478 
important to confirm that the primary infection has cleared and the effector immune 479 
response subsided. For this reason, any mice whose microbial load was above 480 
detection limit (20 CFU for the spleen and 10 CFU for the liver) were not included in 481 
the study.  482 
 483 
ELISPOT and Cytokine Secretion Assay 484 
 485 
The numbers of CD4+ T cells secreting IFN-γ were assessed by ELISPOT and 486 
cytokine secretion assays. For ELISPOT, capture and detection antibodies supplied by 487 
the mouse IFN-γ ELISpot Development Module (R&D Systems) were used according 488 
to manufacturer’s guidelines. Briefly, co-cultures of purified CD4+ T cells with 489 
syngeneic feeder cells were incubated in duplicate wells in the presence or absence of 490 
whole Salmonella cell extract for 12 hours. Cell suspensions were then transferred in 491 
two-fold serial dilutions to a capture antibody-coated 96 well filtration plate 492 
(Millipore) and incubated for a further 12 hours. ELISpot Blue Colour Module (R&D 493 
Systems) analysis of the cell supernatant was performed according to manufacturer’s 494 
guidelines. Data were expressed as IFN-γ spot-forming cells per 106 cells. The 495 
number of CD4+ T cells secreting IFN-γ was also determined using a flow cytometry-496 
based cytokine secretion assay (Miltenyi Biotec) according to manufacturer’s 497 
guidelines. To reduce non-specific background staining and increase sensitivity, cells 498 
were simultaneously stained with a fixable viability dye and anti-mouse CD4 499 
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antibody (clone GK1.5) (both from Invitrogen) while the  sequential gating strategy 500 
used is shown in Supplementary Fig. 2. Data from 100,000 viable cells were acquired 501 
from each mouse using a DxP Multi-color updated FACSCan (BD) analysed with 502 
FlowJo Software (TreeStar).  In subsequent experiments, cells were also stained with 503 
anti-mouse CD44 (clone IM7) and CD62L (clone MEL-14) during cytokine secretion 504 
assay to better characterise the class of memory CD4+ T cells  secreting IFN-γ 505 
(effector or central memory). The sequential gating strategy for these analyses is 506 
shown in Extended Data 3. In this case, data from 100,000 viable cells were acquired 507 
from each mouse using an Attune NxT Flow Cytometer (Invitrogen) and analysed 508 
with FlowJo Software (TreeStar).   509 
 510 
ELISA and Multiplex Immunoassays for Cytokine Quantification 511 
 512 
Cytokine levels were measured in the serum and cell culture supernatant by bead-513 
based, multiple cytokine detection immunoassay and/or ELISA analysis. Mouse 514 
serum was analysed via ELISA for levels of IL-1β (BD OptEIA set) and IL-18 (MBL 515 
International) and via multiplex immunoassays (ProcartaPlex, Invitrogen) for IFN-γ 516 
and TNF-α. Cell culture supernatant harvested from the CD4+ T cell stimulation 517 
assays was analysed by ELISA for levels of IFN-γ and IL-2 (DuoSet Development 518 
kit, R&D Systems) and a flow cytometric, bead based immunoassay (FlowCytomix, 519 
ebioscience) for simultaneous detection of mouse GM-CSF, IL-6, and TNF-α. IL-1β 520 
production from BMDMs infected with Salmonella was also analysed by ELISA. 521 




Detection of Serum Anti-LPS Antibodies 525 
 526 
Antibody (Ab) titers against S. Typhimurium LPS were measured in the serum of 527 
infected and control mice by ELISA as previously described 49. Serum Ab titers were 528 
calculated based on a standard curve constructed by 2-fold serial dilutions of the same 529 
positive serum sample run on every plate. The dilution at which OD450-OD570 of the 530 
standard sample approximated the value of 1 was arbitrarily appointed as 1000 Units. 531 
 532 
Statistical Analyses 533 
 534 
All statistical analyses were performed with GraphPad Prism version 8 with each 535 
specific analysis described in the appropriate figure legend. Exact p values are shown 536 
on each graph separately with p<0.05 considered statistically significant.  537 
 538 
Data Availability 539 
 540 
All data used to generate the figures presented in this work are available in  541 
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FIGURE LEGENDS 779 
 780 
Figure 1. NLRC4 restricts bacterial spread in vivo and Th1 CD4+ T cell-781 
mediated memory responses ex vivo 782 
a, Wild type and Nlrc4-/- mice were challenged i.v. with 9.5x103 CFU S. 783 
Typhimurium M525P and microbial burden was determined in the spleen and liver at 784 
day 1 (n=5 for wild-type and nlrc4-/-), 7 (n=7 for wild-type and n=6 for nlrc4-/-), 14, 785 
21 and 35 (n=6 for wild-type and Nlrc4-/-) post-challenge. b, CD4+ T cells from naïve 786 
wild-type and Nlrc4-/- mice were stimulated ex vivo with medium only (w/o stim.), 787 
anti-mouse CD3e (anti-CD3e) or whole bacterial cell extract (extract). Levels of IFN-788 
γ and IL-2  were measured by ELISA in the cell culture supernatant after 72 and 24 789 
hours, respectively. c, CD4+ T cells from wild-type and Nlrc4-/- mice 90 days after 790 
challenge with 7x103-1x104 CFU of S. Typhimurium M525P were stimulated and 791 
levels of IFN-γ and IL-2 were measured as in b. d, CD4+ T cells from wild-type and 792 
Nlrc4-/- mice 168 days after challenge with 1.15x103 CFU of S. Typhimurium M525P 793 
were stimulated as in b, with the exception that concanavalin A (conA) was used 794 
instead of anti-mouse CD3e, and levels of IFN-γ and IL-2  were measured as in b. e, 795 
CD4+ T cells from wild-type and Nlrc4-/- mice 90 days after challenge with 7x103 796 
CFU of S. Typhimurium M525P were stimulated with whole bacterial cell extract and 797 
levels of IL-6, TNF-α and GM-CSF were measured by fluorescent bead immunoassay 798 
in the cell culture supernatant after 24h. f, Same experiment as e, the number of CD4+ 799 
T cells secreting IFN-γ in response to whole bacterial cell extract was measured via 800 
ELISPOT. g, Wild type and Nlrc4-/- mice were challenged i.v. with 1.72x104 CFU and 801 
112 days later,  the percentage of CD4+ T cells secreting IFN-γ in response to whole 802 
bacterial cell extract was measured via a cytokine secretion assay. Each symbol 803 
 35
represents one mouse with horizontal lines delineate the mean in a. Data are shown as 804 
mean ± SEM in b-g. Data are pooled from two and representative of at least four 805 
independent experiments for c and representative of three for a and two for b, d, e, f 806 
and g independent experiments. Statistical significance was calculated by 2-way 807 
ANOVA followed by Sidak’s multiple comparisons tests for a-d and two-tailed Mann 808 
Whitney test for e-g. 809 
 810 
Figure 2. NLRC4 restricts the magnitude of effector CD4+ T cell responses 811 
during microbial clearance of a primary infection 812 
a, Wild-type and Nlrc4-/- mice were challenged i.v. with 7.2x103-1x104 CFU of S. 813 
Typhimurium M525P and T cell-mediated responses were analysed over time. CD4+ 814 
T cells were co-cultured ex vivo with feeder cells in the presence of medium only (w/o 815 
stim.), anti-mouse CD3e (anti-CD3e), or whole bacterial cell extract (extract) and 816 
IFN-γ was measured by ELISA in the cell culture supernatant after 72 hours. b, Wild-817 
type and Nlrc4-/- mice were challenged i.v. with 7x103 CFU S. Typhimurium M525P 818 
and levels of IgG2b, IgG2c and IgM antibodies against S. Typhimurium LPS were 819 
measured in the serum at 90 days post-challenge via ELISA. Data are shown as mean 820 
± SEM in a. Each symbol represents one mouse with horizontal lines delineate the 821 
mean in b. Statistical significance was assessed by two-tailed Mann Whitney test. 822 
Data are pooled from 2 independent experiments for a: day 7 and generated from one 823 
experiment in a:  day 1, 14, 21 and 35. Data are representative of two independent 824 





Figure 3. NLRC4 restricts the potency of CD4+ T cell-mediated memory 829 
responses against Salmonella in a NLRP3-dependent manner.  830 
The Th1 memory response was assessed by stimulating CD4+ T cells ex vivo with 831 
medium only (w/o stim.), anti-mouse CD3e (anti-CD3e), or whole bacterial cell 832 
extract (extract). a, CD4+ T cells from wild-type and Nlrp3-/- mice 100 days after 833 
challenge with 2.2x104 CFU S. Typhimurium M525P and IFN-γ and IL-2 were 834 
measured by ELISA in the cell culture supernatant after 72 and 24 hours, respectively. 835 
b, CD4+ T cells from wild-type and Nlrp3-/-Nlrc4-/- mice 90 days after challenge with 836 
1.72x104 CFU S. Typhimurium M525P and IFN-γ was measured as in a. c and d, 837 
same experiments as a and b, respectively, the percentage of CD4+ T cells secreting 838 
IFN-γ was measured via a cytokine secretion assay. Data are shown as mean ± SEM. 839 
Statistical significance was calculated using two-tailed, unpaired Student’s t test 840 
assuming equal variances for a and c and two-tailed Mann Whitney test for b and d. 841 
All data are representative of two independent experiments. 842 
 843 
Figure 4. NLRC4 restricts NLRP3-dependent secretion of IL-18 and IFN-γ.  844 
Wild type, Nlrp3-/-, Nlrc4-/- and Nlrp3-/-Nlrc4-/- mice were challenged i.v. with 845 
1.86x104 CFU S. Typhimurium M525P. a, Bacteria were counted in the spleen and 846 
the liver at day 7 (n=5 for wild-type, Nlrp3-/- and Nlrp3-/-Nlrc4-/-  and n=4 for Nlrc4-/-), 847 
21 (n=6 for all genotypes) and 35 (n=6 for wild-type, Nlrp3-/- and Nlrp3-/-Nlrc4-/-  and 848 
n=7 for Nlrc4-/-) post-challenge. b, IL-18 was measured in the serum at day 1 pre-849 
challenge (n=5 for wild-type and Nlrp3-/-Nlrc4-/-, n=4 for Nlrp3-/- and n=6 for Nlrc4-/-) 850 
and day 1 (n=5 for wild-type and n=6 for all other genotypes), 7 (n=5 for wild-type, 851 
Nlrp3-/- and Nlrp3-/-Nlrc4-/-  and n=4 for Nlrc4-/-), 14 (n=6 for wild-type and n=5 for 852 
all other genotypes), 21 ( n=6 for all genotypes), 28 (n=6 for wild-type, Nlrp3-/- and 853 
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Nlrp3-/-Nlrc4-/-  and n=5 for Nlrc4-/-) and 35 (n=6 for wild-type, Nlrp3-/- and Nlrp3-/-854 
Nlrc4-/-  and n=7 for Nlrc4-/-) post-challenge by ELISA. c, IFN-γ was measured by 855 
fluorescent bead immunoassay in the serum over time with the same number of mice 856 
as in b apart from day 1 pre-challenge (n=5 for wild-type and n=4 for all other 857 
genotypes). Each symbol represents one mouse with horizontal lines delineate the 858 
mean in a. Data are shown as mean ± SEM in b-c. Overall statistical significancehas 859 
been determined by one-way ANOVA for each interval separately. For wild-type 860 
versus Nlrc4-/-mice, data are representative of three independent experiments. For 861 
wild-type versus Nlrp3-/- and Nlrp3-/-Nlrc4-/- mice, data are representative of two 862 
independent experiments. 863 
 864 
Figure 5. Salmonella expressing flagellin from non-pathogenic E. coli largely 865 
escapes NLRC4-mediated detection in vivo  866 
Wild type and Nlrc4-/- mice were challenged i.v. with 1.5x104 CFU S. Typhimurium 867 
M525P or M525P fliCMG1655. a, Bacteria were counted in the spleen and the liver of 868 
wild-type mice over time (n=6 for both groups for all days apart from day 35; n=5 for 869 
M525P and n=6 for M525P fliCMG1655) . b, Bacteria were counted in the spleen and 870 
the liver of Nlrc4-/- mice over time (day 4 and 7; n=4 for both groups, day 14 and 28; 871 
n=3 for M525P and n=4 for M525P fliCMG1655). c, IL-18 was measured in the serum 872 
of wild-type mice over time by ELISA with the same number of mice as in a. d, IFN-873 
γ was measured in the serum of wild-type mice over time by a fluorescent bead 874 
immunoassay with the same number of mice as in a. Each symbol represents one 875 
mouse with horizontal lines delineate the mean in a-b. Data are shown as mean ± 876 
SEM in c-d. Statistical significance was calculated by 2-way ANOVA followed by 877 
Sidak’s multiple comparisons tests in a and b and two-tailed Mann Whitney test for 878 
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each time point separately in c and d. All data are representative of two independent 879 
experiments. 880 
 881 
Figure 6. Primary challenge with Salmonella expressing flagellin from non-882 
pathogenic E. coli improves protection against lethal re-challenge  883 
a, CD4+ T cells from wild-type mice 122 days after challenge with 1.5x104 CFU S. 884 
Typhimurium M525P or M525P fliCMG1655 were stimulated with medium only (w/o 885 
stim.), anti-mouse CD3e (anti-CD3e), or whole bacterial cell extract (extract). IFN-γ 886 
was measured by ELISA in the cell culture supernatant after 24 hours. b, Wild-type 887 
mice were challenged with 1.6x104 CFU S. Typhimurium M525P or 1.5x104 CFU 888 
M525P fliCMG1655  and allowed to clear the primary infection for 128 days. They were 889 
then re-challenged orally with 4.8x106 CFU S. Typhimurium SL1344 and euthanized 890 
upon detection of adverse signs. c, In the same experiment as in b, mouse weight was 891 
recorded at least once daily and shown for the first seven days of infection. d, CD4+ T 892 
cells obtained from wild-type and IL-18-/- mice 104 days after primary challenge with 893 
1.6x104 CFU S. Typhimurium M525P were stimulated and IFN-γ was measured as in 894 
a. e, CD4+ T cells obtained from wild-type and IL-18-/- mice 110 days after primary 895 
challenge with 3.3x104 CFU S. Typhimurium M525P fliCMG1655 were stimulated and 896 
IFN-γ was measured as in a. Data are shown as mean ± SEM in a, c, d and e and as a 897 
survival curve in b. Statistical significance was calculated by a two-tailed Mann 898 
Whitney test in a, d and e and two-sided log-rank in b. Data are representative of two 899 
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